Arlene M. Morris
Independent DirectorMs. Arlene M. Morris is Chair of the Board of TC Biopharm Limited. Ms. Morris serves as Independent Director of Edgewise Therapeutics, Inc. since May 2024. She had been an Independent Director of Viveve Medical, Inc. since May 11, 2016 until February 2023. Ms. Morris has been Non Executive Independent Director of TC Biopharm (Holdings) Plc since February 2022 and also serves as Chairman. She serves as an Independent Director at Cogent Biosciences, Inc. since July 29, 2019. She has served as Chief Executive Officer of Willow Advisors, LLC since May 2015. Ms. Morris has management experience from Johnson & Johnson’s Ortho McNeil Pharmaceutical, Scios, Inc., Corixa Corporation and Clearview Projects, Inc. She served as the Chief Executive Officer of Syndax Pharmaceuticals, Inc. from April 2012 to May 12, 2015. She served as President Syndax Pharmaceuticals, Inc. from September 2013 to May 12, 2015. Ms. Morris was a Consultant of Affymax, Inc. from February 1, 2011 to September 30, 2011. She served as the Chief Executive Officer of Affymax, Inc. from June 2003 to January 2011. She served as President of Affymax, Inc. from June 2003 to April 2010. Ms. Morris served as the Chief Executive Officer and President of Clearview Projects Inc. from 2001 to 2003. She served as a Senior Vice President of Business Development at Corixa. Ms. Morris served as a Senior Vice President of Business Development at Coulter Pharmaceutical, Inc. since February 2000. From October 1996 to January 2000, she served as a Vice President of Business Development of Coulter Pharmaceuticals Inc. Ms. Morris served as a Vice President of Business Development at Scios, Inc. from April 1993 to October 1996. From 1977 to 1993, she held various management and executive positions at Johnson & Johnson in sales, marketing and business development, holding the position of Vice President of Business Development for McNeil Pharmaceutical from November 1988 to April 1993. Ms. Morris served as Chairman of Nuon Therapeutics, Inc. since July 2009. Ms. Morris served as Directors of Neovacs S. A. from May 4, 2011 to July 15, 2020. Ms. Morris has been an Independent Director of Viridian Therapeutics, Inc. (Formerly known as Miragen Therapeutics, Inc.) since January 03, 2018. She joined the Viridian Therapeutics, Inc. on January 03, 2018. Ms. Morris serves as a Director of Biotechnology Innovation Organization and Humane Society Silicon Valley. She has been an Independent Director of Palatin Technologies Inc. since June 2015. Ms. Morris served as a Director of Biodel Inc. from May 18, 2015 to 2016. She served as a Director of Dimension Therapeutics, Inc. from August 11, 2015 to 2018. Ms. Morris served as a Director of Medicinova Inc. from May 11, 2006 to June 14, 2013. She served as an Executive Director of Affymax, Inc. from 2003 to February 1, 2011. Ms. Morris served as a Director of Phenomix Corporation since October 2007 and Syndax Pharmaceuticals, Inc. since May 2011 until May 2015. She served as a Director of the Licensing Executives Society and EmerGen, Inc. She has also served as a Board Chair for the Foundation for Research and Development at the Medical University of South Carolina as a Trustee of Carlow University. Ms. Morris serves as a Director of MUSC Foundation for Research and Development and BIO (U. S. A). Ms. Morris holds BA in Biology and Chemistry from Carlow College and studied Marketing at Western New England College from 1969 to 1974.
Positions
- Company NamePalatin Technologies, Inc.Stock CodePTNPositionIndependent DirectorColleagues
- CSCarl SpanaCo-Founder, President, CEO & Director
- JKJohn K. A. PrendergastIndependent Non-Executive Chairman
- STStephen T. WillsCFO, COO, Executive VP, Treasurer & Secretary
- BMBurns McClellanVice President of Investor Relations
- SAStephen A. SlusherChief Legal Officer
- JEJames E. HattersleySenior Vice President of Business Development
- AWAlan W. DuntonIndependent Director
- AMArlene M. MorrisIndependent Director
- RCRaymond C. RosenMember of Female Sexual Dysfunction Expert Panel
- Company NameCogent Biosciences, Inc.Stock CodeCOGTPositionIndependent DirectorColleagues
- ARAndrew R. RobbinsPresident, CEO & Director
- PEPeter Evan HarwinIndependent Chairman of the Board
- JLJohn L. GreenCFO & Principal Accounting Officer
- JEJohn Edward RobinsonChief Scientific Officer
- JSJessica SachsChief Medical Officer
- CPCole PinnowChief Commercial Officer
- KJKaren Jean FerranteIndependent Director
- AMArlene M. MorrisIndependent Director
- TETodd E. ShegogIndependent Director
- Company NameTC Biopharm (Holdings) PlcStock CodeTCBWFPositionNon-Executive Independent ChairColleagues
